Sangamo Therapeutics Inc (NASDAQ:SGMO)

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 11.00, with a high estimate of 30.00 and a low estimate of 6.00. The median estimate represents a -14.73% decrease from the last price of 12.90.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Sangamo Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over pastmonths for detail

Earnings and Sales Forecasts

Current Quarter

Earnings per Share-$0.21

Sales$10.4M

Reporting DateOct 25

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.